Conceivably, one or more of these other family members may also be targeting IGF1R in ccRCC and therefore may cooperate in an additive manner to enhance regulation of IGF1R—as well as potentially other oncogenes. This evidence concerns the gene IGF1R and nonpapillary renal cell carcinoma.